Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Asahi Kasei A Bpep"

03:07 EDT 26th July 2014 | BioPortfolio

Matching Channels

None

Matching News

Asahi Kasei Corporation: Company Profile and SWOT Analysis

Recently added to the BioPortfolio report store, Asahi Kasei Corporation: Company Profile and SWOT Analysis is a new report from ICD Research published on 2011-09-09. This 35-page report is availabl...

RaQualia and Asahi Kasei Pharma progress their collaboration

RaQualia Pharma says that its ongoing joint research with fellow Japanese drugmaker Asahi Kasei Pharma has moved to a new phase. Following the positive results from the collaborative research under th...

US Court upholds damages award in Actelion/Asahi litigation

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for review of the Court of Appeal's decision affirming the final judgment entered against Actelion in...

Actelion, Asahi Kasei Pharma, Washington Legal Foundation cardiovascular news

CoAxia sells all of its assets to Zoll Medical

Emergency care device manufacturer Zoll Medical Corp., bought last year for $1.2bn by Japanese diversified company Asahi Kasei Corp., has acquired all of the assets of privately held CoAxia Inc. (inst...

Roughly 90% Of Large Japanese Companies Extend Care Leave: Asahi Survey

With the turnover of nursing and care employees being 100,000 per year in Japan, roughly 90% of large companies in the country are extending nursing leave to a period longer than that required by law,...

Paralysis Clinical Trials H1 Review Global Analysis to 2014 Report Available at MarketOptimizer.org

MarketOptimizer.org adds “Paralysis Global Clinical Trials Review, H1, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Paralysis. Dallas,...

New Japanese Test Train Uses Special Glass Developed by Asahi Glass Co. Using Research Frontiers Patented SPD-SmartGlass Technology

TOKYO and WOODBURY, N.Y., April 23, 2014 (GLOBE NEWSWIRE) -- Earlier today, Asahi Glass Co. (AGC) President & CEO, Kazuhiko Ishimura announced that AGC's new lightweight light control glass using...

Matching PubMed Articles

Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement